Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term biological efficacy and tolerability of Vedrop in pediatric cystic fibrosis
2007-001007-38Phase 2Active
- Sponsor
- Orphan Therapeutics Accelerator
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tocofersolan in cystic fibrosis (CF), sponsored by Orphan Therapeutics Accelerator. Started Mar 2007; status: active.
02
Drugs
tocofersolan
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on 2007-001007-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001007-38.